Get started
Author

Ralph C. Winterhalder

Observed names: R. C. Winterhalder, R.C. Winterhalder, Ralph Winterhalder, Ralph Winterhalder C, Winterhalder, Winterhalder, R, Winterhalder, R., Winterhalder, R. C., Winterhalder, Ralph, Winterhalder, Ralph C, Winterhalder, Ralph C.
OpenAlex ID: A5108116669
Chemoprevention of lung cancer—from biology to clinical reality
2004 · R.C. Winterhalder, F.R. Hirsch, et al. · Annals of Oncology · 46
PDF
Bevacizumab continuation versus no continuation after first-line chemo-bevacizumab therapy in patients with metastatic colorectal cancer: A randomized phase III noninferiority trial (SAKK 41/06).
2013 · Dieter Koeberle, Daniel C. Betticher, et al. · Journal of Clinical Oncology · 29
Cetuximab monotherapy and cetuximab plus capecitabine as first-line treatment in older patients with RAS- and BRAF wild-type metastatic colorectal cancer. Results of the multicenter phase II trial SAKK 41/10
2018 · Dirk L. Kienle, Daniel Dietrich, et al. · Journal of Geriatric Oncology · 28
Neoadjuvant radiotherapy combined with capecitabine and sorafenib in patients with advanced KRAS -mutated rectal cancer: A phase I/II trial (SAKK 41/08)
2017 · Roger von Moos, Dieter Koeberle, et al. · European Journal of Cancer · 26
Prevention of palmar–plantar erythrodysesthesia with an antiperspirant in breast cancer patients treated with pegylated liposomal doxorubicin (SAKK 92/08)
2014 · Arnoud J. Templeton, Karin Ribi, et al. · The Breast · 21
Orteronel Switch Maintenance Therapy in Metastatic Castration Resistant Prostate Cancer After First-Line Docetaxel: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial (SAKK 08/11)
2016 · Richard Cathomas, Simon J. Crabb, et al. · The Prostate · 19
PDF
SAKK 24/09: Safety and tolerability of bevacizumab plus paclitaxel versus bevacizumab plus metronomic cyclophosphamide and capecitabine as first-line therapy in patients with HER2-negative advanced stage breast cancer—A multicenter, randomized phase III trial.
2014 · Christoph Rochlitz, Roger von Moos, et al. · Journal of Clinical Oncology · 14
Incidence of hypocalcemia in patients with castration-resistant prostate cancer treated with denosumab: Data from a non-inferiority phase III trial assessing prevention of symptomatic skeletal events (SSE) with denosumab administered every four weeks (q4w) versus every 12 weeks (q12w)—SAKK 96/12 (REDUSE).
2019 · Silke Gillessen, Roger Anton Fredy Von Moos, et al. · Journal of Clinical Oncology · 12
268P Anti-EGFR-immunoliposomes loaded with doxorubicin in patients with advanced triple-negative, EGFR positive breast cancer: A multicenter single arm phase II trial [SAKK 24/14]
2021 · A. Wicki, C. Mamot, et al. · Annals of Oncology · 6
Neoadjuvant radiotherapy (RT) combined with capecitabine (Cape) and sorafenib (Sor) in patients (pts) with locally advanced, k-ras-mutated rectal cancer (LARC): A phase I/II trial SAKK 41/08.
2014 · Roger Von Moos, Dieter Koeberle, et al. · Journal of Clinical Oncology · 5
Prevention of palmoplantar erythrodysesthesia (PPE) with an antiperspirant in breast cancer patients treated with pegylated liposomal doxorubicin (PLD), a placebo-controlled, double blinded, phase lll trial (SAKK 92/08).
2012 · Thomas Ruhstaller, Karin Ribi, et al. · Journal of Clinical Oncology · 4
Neoadjuvant chemoradiation (CRT) with or without panitumumab (Pan) in patients with K-ras-unmutated, locally advanced rectal cancer (LARC): A randomized multicenter phase II trial (SAKK 41/07).
2011 · D. Helbling, G. Bodoky, et al. · Journal of Clinical Oncology · 4
Everolimus as first-line therapy in nonrapidly progressive metastatic castration-resistant prostate cancer (mCRPC): A multicenter phase II trial (SAKK 08/08).
2011 · A. Templeton, C. Rothermundt, et al. · Journal of Clinical Oncology · 4
Cetuximab in combination with docetaxel in patients (pts) with metastatic castration resistant (mCRPC) and docetaxel-refractory prostate cancer: A multicenter phase II trial (SAKK 08/07).
2010 · R. Cathomas, C. Rothermundt, et al. · Journal of Clinical Oncology · 2
Das Prostatakarzinom: Eine Übersicht aktueller Behandlungsstrategien
2009 · Winterhalder · Praxis · 2
Onkologische Notfälle
2008 · R.C. Winterhalder, B. Müller · Praxis · 2
Ablatio-bilica: safety of biliary intraductal radiofrequency ablation in patients with unresectable extrahepatic biliary tract cancer undergoing systemic anti-tumor therapy: a phase II, multi-center, randomized, and controlled study
2026 · Tabea Pfister, Samantha Chun Wai Chan, et al. · Frontiers in Oncology · 1
PDF
431P Neoadjuvant treatment with regorafenib and capecitabine combined with radiotherapy in locally advanced rectal cancer: A multicenter phase Ib trial (RECAP) SAKK 41/16
2022 · S. Bastian, M. Joerger, et al. · Annals of Oncology · 1
1943 Adjuvant treatment recommendations for ER+ early breast cancer patients by Swiss tumor boards (SAKK 26/10)
2015 · B.C. Pestalozzi, C. Tausch, et al. · European Journal of Cancer · 1
1971 A correlative study of Ki67 and two multigene RNA expression signatures in operable ER-positive postmenopausal breast cancer (SAKK 26/10)
2015 · R. Jaggi, Z. Varga, et al. · European Journal of Cancer · 1
Metformin in chemotherapy-naive castration-resistant prostate cancer: a multicenter phase 2 trial (SAKK 08/09)
2014 · Rothermundt, Christian, Hayoz, Stefanie, et al. · Zurich Open Repository and Archive (University of Zurich) · 1
Metformin in Chemotherapy-Naïve Castration Resistant Prostate Cancer (CRPC): A Multicenter Phase II Trial (SAKK 08/09)
2012 · C.A. Rothermundt, R. Cathomas, et al. · Annals of Oncology · 1
Neoadjuvant radiotherapy (RT) combined with capecitabine (Cape) and sorafenib (Sor) in patients with locally advanced, K-ras-mutated rectal cancer (LARC): A phase I/II trial (SAKK 41/08).
2012 · Roger Von Moos, Dieter Koeberle, et al. · Journal of Clinical Oncology · 1
Neoadjuvant Treatment With Regorafenib and Capecitabine Combined With Radiotherapy in Locally Advanced Rectal Cancer: A Multicenter Phase Ib Trial (RECAP)-SAKK 41/16
2025 · Bastian, Sara, Joerger, Markus; https://orcid.org/0000-0001-6602-6287, et al. · Zurich Open Repository and Archive (University of Zurich)
Neoadjuvant Treatment With Regorafenib and Capecitabine Combined With Radiotherapy in Locally Advanced Rectal Cancer: A Multicenter Phase Ib Trial (RECAP)–SAKK 41/16
2024 · Sara Bastian, Markus Joerger, et al. · Clinical Colorectal Cancer
PDF
Works count: 47
Citation count: 231
H-index: 8
I10-index: 8
Year
Topic
Type